A Double Blind Study of the Effect of Tranexamic Acid in Essential Menorrhagia

Abstract

Oral administration of tranexamic acid, in a dosage of 3 g daily from the first day of menstruation onwards, significantly decreases menstrual haemoglobin loss in women with so-called essential menorrhagia. The frequency of side-effects reported did not differ between “active” and “placebo” periods.